Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Next Generation Bioprinting Market Snapshot
Chapter 4. Global Next Generation Bioprinting Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type:
5.2.1. Extrusion-based Technology
5.2.2. Laser-based Technology
5.2.3. Inkjet-based Technology
5.2.4. Others
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Type & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
6.2.1. Biomedical Applications
6.2.2. Other Application
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By Type & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User:
7.2.1. Pharmaceutical and Biotechnology Companies
7.2.2. Academic Research and Development
7.2.3. Other End-users
Chapter 8. Next Generation Bioprinting Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By Type, 2024-2031
8.1.2. North America Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.1.3. North America Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By End User, 2024-2031
8.1.4. North America Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
8.1.5. U.S.
8.1.6. Canada
8.2. Europe
8.2.1. Europe Next Generation Bioprinting Market revenue (US$ Million) By Type, 2024-2031
8.2.2. Europe Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.2.3. Europe Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By End User 2024-2031
8.2.4. Europe Next Generation Bioprinting Market revenue (US$ Million) by country, 2024-2031
8.2.5. Germany
8.2.6. Poland
8.2.7. France
8.2.8. Italy
8.2.9. Spain
8.2.10. UK
8.2.11. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Next Generation Bioprinting Market revenue (US$ Million) By Type, 2024-2031
8.3.2. Asia Pacific Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.3.3. Asia Pacific Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By End User, 2024-2031
8.3.4. Asia Pacific Next Generation Bioprinting Market revenue (US$ Million) by country, 2024-2031
8.3.5. China
8.3.6. India
8.3.7. Japan
8.3.8. Australia
8.3.9. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Next Generation Bioprinting Market revenue (US$ Million) By Type, 2024-2031
8.4.2. Latin America Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.4.3. Latin America Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By End User, 2024-2031
8.4.4. Latin America Next Generation Bioprinting Market revenue (US$ Million) by country, (US$ Million) 2024-2031
8.4.5. Brazil
8.4.6. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa Next Generation Bioprinting Market revenue (US$ Million) By Type, (US$ Million) 2024-2031
8.5.2. Middle East & Africa Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.5.3. Middle East & Africa Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By End User, 2024-2031
8.5.4. Middle East & Africa Next Generation Bioprinting Market revenue (US$ Million) by country, (US$ Million) 2024-2031
8.5.5. South Africa
8.5.6. GCC Countries
8.5.7. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. DirectSync Surgical
9.2.2. Poietis
9.2.3. Regenhu
9.2.4. 3D Systems, Inc.
9.2.5. GeSiM
9.2.6. Stratasys
9.2.7. ROKIT Healthcare
9.2.8. Sculpteo
9.2.9. Smart3D
9.2.10. VIVAX BIO
9.2.11. EnvisionTec
9.2.12. EOS GmbH Electro Optical System
9.2.13. Materialise NV
9.2.14. Dassault Systèmes
9.2.15. Organovo Holdings, Inc.
9.2.16. CellLink
9.2.17. Izumi International, Inc
9.2.18. Advanced Solutions Life Sciences. LLC
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.